124 related articles for article (PubMed ID: 3766375)
21. Demonstration of proarrhythmic activity with the class IC antiarrhythmic agent encainide in a canine model of previous myocardial infarction.
Wallace AA; Stupienski RF; Kothstein T; Gehret JR; Lynch JJ
J Cardiovasc Pharmacol; 1993 Mar; 21(3):397-404. PubMed ID: 7681500
[TBL] [Abstract][Full Text] [Related]
22. Failure of lidocaine to suppress lethal ischemic ventricular arrhythmias in a canine model of previous myocardial infarction.
Lynch JJ; Heaney LA; Wallace AA; Gehret JR; Stein RB
J Cardiovasc Pharmacol; 1990 Jul; 16(1):41-9. PubMed ID: 1696665
[TBL] [Abstract][Full Text] [Related]
23. Results of signal-averaged electrocardiography and electrophysiologic study in patients with nonsustained ventricular tachycardia after healing of acute myocardial infarction.
Buxton AE; Simson MB; Falcone RA; Marchlinski FE; Doherty JU; Josephson ME
Am J Cardiol; 1987 Jul; 60(1):80-5. PubMed ID: 3604948
[TBL] [Abstract][Full Text] [Related]
24. Pirmenol: preclinical pharmacology.
Kaplan HR; Mertz TE; Steffe TJ
Angiology; 1988 Mar; 39(3 Pt 2):281-92. PubMed ID: 3281517
[TBL] [Abstract][Full Text] [Related]
25. Electrophysiologic effects of E-4031, a class III antiarrhythmic agent, on re-entrant ventricular arrhythmias in a canine 7-day-old myocardial infarction model.
Katoh H; Ogawa S; Furuno I; Sato Y; Yoh S; Saeki K; Nakamura Y
J Pharmacol Exp Ther; 1990 Jun; 253(3):1077-82. PubMed ID: 2359016
[TBL] [Abstract][Full Text] [Related]
26. Cardiac electrophysiologic and antiarrhythmic actions of two long-acting spirobenzopyran piperidine class III agents, L-702,958 and L-706,000 [MK-499].
Lynch JJ; Wallace AA; Stupienski RF; Baskin EP; Beare CM; Appleby SD; Salata JJ; Jurkiewicz NK; Sanguinetti MC; Stein RB
J Pharmacol Exp Ther; 1994 May; 269(2):541-54. PubMed ID: 7802864
[TBL] [Abstract][Full Text] [Related]
27. Cellular electrophysiologic characteristics of surviving subendocardial fibers in chronically infarcted right ventricular myocardium susceptible to inducible sustained ventricular tachycardia.
Sugi K; Karagueuzian HS; Fishbein MC; Mandel WJ; Peter T
Am Heart J; 1987 Sep; 114(3):559-69. PubMed ID: 3630897
[TBL] [Abstract][Full Text] [Related]
28. Programmed electrical stimulation in healed myocardial infarction using a standardized ventricular stimulation protocol.
Zehender M; Brugada P; Geibel A; Waldecker B; Stevenson W; Wellens HJ
Am J Cardiol; 1987 Mar; 59(6):578-85. PubMed ID: 3825897
[TBL] [Abstract][Full Text] [Related]
29. Facilitation of reentry by lidocaine in canine myocardial infarction.
Fazekas T; Scherlag BJ; Mabo P; Patterson E; Lazzara R
Am Heart J; 1994 Feb; 127(2):345-52. PubMed ID: 7507635
[TBL] [Abstract][Full Text] [Related]
30. Reproducibility of programmed electrical stimulation responses in patients with ventricular tachycardia or fibrillation associated with coronary artery disease.
Volgman AS; Zheutlin TA; Mattioni TA; Parker MA; Kehoe RF
Am J Cardiol; 1992 Sep; 70(7):758-63. PubMed ID: 1519526
[TBL] [Abstract][Full Text] [Related]
31. Serial analysis of electrically induced ventricular arrhythmias in a canine model of myocardial infarction.
Garan H; Ruskin JN; McGovern B; Grant G
J Am Coll Cardiol; 1985 May; 5(5):1095-106. PubMed ID: 3989120
[TBL] [Abstract][Full Text] [Related]
32. Conduction velocity depression and drug-induced ventricular tachyarrhythmias. Effects of lidocaine in the intact canine heart.
Anderson KP; Walker R; Lux RL; Ershler PR; Menlove R; Williams MR; Krall R; Moddrelle D
Circulation; 1990 Mar; 81(3):1024-38. PubMed ID: 2155070
[TBL] [Abstract][Full Text] [Related]
33. Electrophysiologic actions of BRB-I-28 in ischemically injured canine myocardium.
Patterson E; Scherlag BJ; Berlin KD; Lazzara R
J Cardiovasc Pharmacol; 1993 Apr; 21(4):637-46. PubMed ID: 7681911
[TBL] [Abstract][Full Text] [Related]
34. Sustained ventricular tachyarrhythmias during the early postinfarction period: electrophysiologic findings and prognosis for survival.
Marchlinski FE; Waxman HL; Buxton AE; Josephson ME
J Am Coll Cardiol; 1983 Aug; 2(2):240-50. PubMed ID: 6863760
[TBL] [Abstract][Full Text] [Related]
35. Ventricular tachyarrhythmia initiation in a canine model of recent myocardial infarction. Comparison of unipolar cathodal, anodal and bipolar stimulation.
Ohm OJ; Mitamura H; Michelson EL; Sauermelch C; Dreifus LS
Cardiology; 1987; 74(3):169-81. PubMed ID: 3594506
[TBL] [Abstract][Full Text] [Related]
36. Development of ventricular tachyarrhythmias in the conscious canine during the recovery phase of experimental ischemic injury: effect of bethanidine administration.
Patterson E; Amalfitano DJ; Lucchesi BR
J Cardiovasc Pharmacol; 1984; 6(3):470-5. PubMed ID: 6202974
[TBL] [Abstract][Full Text] [Related]
37. Effects of flecainide acetate on ventricular tachyarrhythmia and fibrillation in dogs with recent myocardial infarction.
Lynch JJ; DiCarlo LA; Montgomery DG; Lucchesi BR
Pharmacology; 1987; 35(4):181-93. PubMed ID: 3118399
[TBL] [Abstract][Full Text] [Related]
38. Cardiac electrophysiologic and antiarrhythmic actions of 3,4-dihydro-1'-[2-(benzofurazan-5-yl) ethyl]-6-methanesulfonamidospiro [(2H)-1-benzopyran-2,4'-piperidin]-4-one HCl (L-691,121), a novel class III agent.
Lynch JJ; Wallace AA; Van der Gaag LH; Baskin EP; Bear CM; Gehret JR; Kothstein T; Stupienski RF; Appleby SD; Sanguinetti MC
J Pharmacol Exp Ther; 1993 May; 265(2):720-30. PubMed ID: 8496818
[TBL] [Abstract][Full Text] [Related]
39. Actions of disopyramide on potential reentrant pathways and ventricular tachyarrhythmias in conscious dogs during the late post-myocardial infarction phase.
Cobbe SM; Hoffmann E; Ritzenhoff A; Brachmann J; Kübler W; Senges J
Am J Cardiol; 1984 Jun; 53(11):1712-8. PubMed ID: 6731317
[TBL] [Abstract][Full Text] [Related]
40. Electrophysiologic and antiarrhythmic actions of sulphinpyrazone and its sulfide metabolite G25671.
Eller BT; Lynch JJ; Patterson E; Lucchesi BR
Pharmacology; 1987; 34(2-3):121-30. PubMed ID: 3108907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
